Effects of low dose tamoxifen on normal breast tissue from premenopausal women

By de Lima G.R.   Facina G.   Shida J.Y.   Chein M.B.C.   Tanaka P.   Dardes R.C.   Jordan V.C.   Gebrim L.H.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 891-898

Elsevier

Access to resources Recommend Favorite

Use of raloxifene among women with a history of breast cancer

By Habel Laurel A.   Pressman Alice   Ettinger Bruce   Sidney Stephen   Suh-Burgmann Betty   Fehrenbacher Louis   Quesenberry Charles P.  

Breast Cancer Research and Treatment, Vol. 96, Iss. 2, 2006-03 ,pp. : 123-129

Springer Publishing Company

Access to resources Recommend Favorite

Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

By Cauley J.A.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 2, 2001-01 ,pp. : 125-134

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study

By Rosal Marta  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 797-801

Springer Publishing Company

Access to resources Recommend Favorite

Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer

By Love Richard  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 479-485

Springer Publishing Company

Access to resources Recommend Favorite